tbuckley/cabot-search huggingface dataset:
BUDAPEST
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PULSE
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatitis C viral (HCV) infection and liver transplantation (LT) ? relation of outcome to posttransplant steroid use ? Depts of Digestive Surgery, Virology*, Intensive Care** ? Univ. Hospital St-Luc ? Catholic Univ. of Louvain ? Brussels ? Belgium
Journal: Hepatology (1995)

IR, Raman and single-crystal Raman spectra of laurionite-type Sr(OH)I, Ba(OH)Cl, Ba(OH)Br, Ba(OH)I, Pb(OH)Cl, Pb(OH)Br and Pb(OH)I, and of deuterated specimens and Ba(OH)Cl1−xBrx, solid solutions recorded at 90–520 K are presented and assigned to OH (OD) stretching, librational and translational modes. The main results obtained are (i) unusually large structural H/D isotope effects of Ba(OH)Cl due to Landau-type isostructural reorientation of OH− ions and (ii) the very different nature and strengths of the hydrogen bonds formed. Thus, the strengths of the partly linear (Ba(OH)Cl), partly multifurcated hydrogen bonds range as Pb(OH)I (vOH: 3497 cm−1) > Pb(OH)Br > Pb(OH)Cl > Sr(OH)I (3591 cm−1), as shown by the red-shift of the OH stretches and the blue-shift of the OH librations. In the cases of Ba(OH)Br (3605 cm−1) and Ba(OH)I (3590 cm−1), hydrogen bonding is negligible. The stronger hydrogen bonds formed in the lead compounds are caused by the greater synergetic effect of Pb2+ ions compared to those of Sr2+ and Ba2+.
Jugular Vein Sampling in Cushing Disease
Authors: John L. Doppman
Journal: Annals of Internal Medicine (1998)

Letters1 September 1998Jugular Vein Sampling in Cushing DiseaseJohn L. Doppman, MD, Lynnette Nieman, MD, and Edward Oldfield, MDJohn L. Doppman, MDNational Institutes of Health; Bethesda, MD 20892Search for more papers by this author, Lynnette Nieman, MDNational Institutes of Health; Bethesda, MD 20892Search for more papers by this author, and Edward Oldfield, MDNational Institutes of Health; Bethesda, MD 20892Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-129-5-199809010-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:As noted by Dr. Thaler, there is a discrepancy between the lower boundaries of the ranges of the central-to-peripheral ACTH ratios described in the Results section and the ranges of the data shown in the figure. The reason for this discrepancy is that the figure presents all the data, whereas the ranges presented in the Results section refer just to those cases with positive sampling results (that is, ratios >2 before and >3 after CRH administration). Previously in the text we had commented that 16 of 20 patients (80%) with surgically proven Cushing disease had positive findings on ...References1. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotrophin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991; 325:897-905. Google Scholar Author, Article, and Disclosure InformationAffiliations: National Institutes of Health; Bethesda, MD 20892 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 September 1998Volume 129, Issue 5Page: 424KeywordsAdrenocorticotropic hormoneJugular veinSpecificityVeins ePublished: 15 August 2000 Issue Published: 1 September 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Legal Issues in Medicine — A New Series
Journal: New England Journal of Medicine (1991)

With this issue of the Journal we begin a new series of commentaries on the legal aspects of medicine, entitled "Legal Issues in Medicine" and written by George J. Annas, J.D., M.P.H., who is Edward R. Utley Professor of Health Law and director of the Law, Medicine, and Ethics Program at the Boston University Schools of Medicine and Public Health.As this new series begins, William J. Curran's "LawMedicine Notes," since 1964 a regular and highly successful feature of the Journal, ends. Professor Curran has been extremely influential in shaping the field of medical law from its infancy, as . . .
HLA-B27 antigen in women with ankylosing spondylitis
Authors: P. M. Levitin
Journal: JAMA (1976)

Twenty-three (85.2%) of 27 female patients with ankylosing spondylitis were positive for HLA-B27 antigen, including 15 of 18 white women (83.3%) and eight of nine black women (88.9%). Ankylosing spondylitis in women appears to have the same high association with HLA-B27 antigen as that reported in predominantly male studies (88% to 96%). Determination of this antigen may be useful in the evaluation of female patients suspected of having ankylosing spondylitis. (<i>JAMA</i>235:2621-2622, 1976)
From the Centers for Disease Control and Prevention. Estimates of future global tuberculosis morbidity and mortality
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Malignant Degeneration and Extensive Metastasis in Peutz-Jeghers Syndrome
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cervical Cancer Control—Rhode Island
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Wording and Level Errors
Journal: JAMA (2001)

In Reply: We agree with all these authors that it would be useful to calculate an overall accuracy of ultrasound screening for fetal Down syndrome when structural abnormalities and ultrasonographic markers are used together.Unfortunately, studies that reported a composite ultrasound score (n=18) reported statistically inconsistent results, and thus a reliable summary estimate could not be generated.The mean sensitivity (68%) and mean false-positive rate (8%) are not reliable, and we did not include them in the expected outcome data.It is meaningless to use these values to generate positive and negative LRs as the authors of these letters suggest.Although it is likely that a normal ultrasound result demonstrating no structural abnormalities or markers can reduce the liklihood of Down syndrome, the amount of this reduction is not known, and Dr Nyberg's estimate of a negative LR of 0.34 is not supported by our data.Furthermore, there are reasons to believe that the true accuracy of the composite score is lower than we reported.First, we found significant differences in the sensitivity by study design, and if we excluded the case control studies, which are likely to overestimate accuracy, 1 the mean detection was only 58%.Second, most included studies were confined to high-risk pregnancies, and if ultrasound screening was used in a lower-risk population, the detection rate would likely be lower than we reported. 2 We focused on isolated ultrasonographic markers because these results showed the most consistent data, and because in clinical practice, this is the most common occurrence.Most pregnant women are at low risk of having a fetus with Down syndrome, and markers will predominantly be identified as isolated abnormalities.We agree with Nyberg that the presence of a single ultrasonographic marker in most patients should not alter treatment.However, we strongly disagree about the nature of the current clinical practice.Detection of these markers has dramatically increased the use of invasive testing, 3 and many physicians counsel their patients that they are at an elevated risk of carrying a fetus with Down syndrome based on the presence of a single marker.In addition to unnecessary invasive tests performed because of the presence of markers, the psychological impact cannot be overstated. 4 We defined high risk as 1:300, equivalent to the risk of Down syndrome in a 35-year-old woman, and the same threshold used by many serum testing programs. 5If we had used the mean risk among all women older than age 35 years instead, this would have resulted in a higher PPV but would not have altered the low-detection rate or low LRs.We agree with Dr Egan and colleagues that advanced maternal age-based screening for Down syndrome is not accurate, but there is no evidence that ultrasound screening would be as accurate as biochemical screening. 5If women who are at an elevated risk of carrying a fetus with Down syndrome based on serum testing results are dissuaded from undergoing amniocentesis because of the absence of ultrasonographic markers, the detection of affected pregnancies will
Brain Bank
Authors: Rebecca Voelker
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical Priorities
Authors: John Lister
Journal: New England Journal of Medicine (1968)

THE National Health Service celebrated its 20th anniversary on July 5, and in a special article in The Times,1 Dr. David Owen, M.P., reflected upon its achievements and its prospects. He claimed that it had largely succeeded in its major goal of providing a service universal in its cover, where the available skill and equipment are mobilized, not on the criterion of an ability to pay but on a humane assessment of the individual patient. Furthermore, he emphasized that the relevant but little publicized fact about the Health Service is the degree of public support that it has always . . .
Harvest
Authors: Tony Miksanek
Journal: JAMA (1997)

<i>Harvest</i>is a thoughtful medical thriller by internist Tess Gerritsen. Her novel suggests that any decision in medicine, no matter how clinically, ethically, or personally correct, can generate a ripple effect with dire consequences. In the case of fictional second-year surgical resident Dr Abby DiMatteo, doing the right thing unleashes a cascade of events that threatens not only her career but her life. The 28-year-old physician unwittingly becomes entangled in a horrifying conspiracy orchestrated by the Russian mafia. Orphaned boys, ages 10 to 15, are murdered and their organs harvested to provide transplants for those who can afford to bypass the waiting list. Some of the characters seem a bit stereotyped, like Dr Colin Wettig, the chairman of the surgical residency program, and Bernard "Slug" Katzka, a homicide detective. The stunted but wise 11-year-old Russian orphan Yakov is an exception. This youngster, with a withered stump in place of his
MISCELLANEOUS.
Journal: JAMA (1883)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dosimetry of scattered radiation to the fetus
Authors: E. E. Covington
Journal: JAMA (1969)

Measurement of scattered radiation to the fetus during radiation therapy for Hodgkin's disease of the mediastinum was 0.0026 rads per rad given to the tumor, or 7.9 rads for 14 treatments or 3,500 rads. Measurements of scattered radiation made on a phantom for three different modalities indicate the scattered dose to a fetus would be 3.5 to 14 rads in early pregnancy, 31 to 49 rads in midpregnancy, and 129 to 248 rads in late pregnancy, for 14 treatments or 3,500 rads.
Improving clinical outcomes in elderly oncology patients
Authors: T. W. Gillespie, H. Patterson, W. B. Harris, M. Shumate, P. Nadella, J. Jacobs, M. J. Ribeiro
Journal: Journal of Clinical Oncology (2004)

6075 Background: Clinical decision-making for elderly patients with cancer is often challenged by limited outcome data from clinical trials; concerns regarding toxicities and co-morbidities; and inability to readily select patients who might tolerate more intensive therapy. Thus, chronological age is often used as the primary criteria for decisions. Multidisciplinary assessment of aging can be performed using the Comprehensive Geriatric Assessment (CGA) tool. The Screening Geriatric Assessment (SGA) is a briefer version and may quickly predict older patients who might tolerate standard therapy. Methods: A prospective trial (N=57) was conducted to determine the role of SGA in treatment decision-making and improving clinical outcomes. Published evidence, NCCN guidelines for the elderly, and consensus of clinicians at the Atlanta VA Medical Center were used to develop treatment standards for all stages/cell types of non-small cell lung cancer(N=39) or non-Hodgkin's lymphoma (N=18). Consenting patients at point of clinical decision-making were enrolled into Cohort A (age ≥ 65; N=29) or B (age 50–64; N=28). All patients were screened for functionality and given an objective score based on the SGA at time of enrollment. Scores were used to assign patients to category 1 (standard care), 2 (equivocal; CGA also given), or 3 (frailty). Results: No significant difference in SGA scores was found for Cohort A vs. younger subjects. Significantly more older patients (75%) were able to finish their prescribed treatment, both radiation and chemotherapy, compared to the younger cohort (47%) (p=0.012). Strong negative correlation was found between relative dose intensity (RDI) delivered and SGA category (p=.005). A regression model was developed that explained 40% of the variance for RDI delivered; primary predictors were thrombocytopenia and febrile neutropenia (p=.04; adjusted r2 =.24). Conclusions: The SGA may serve to promote use of standard-of-care to treat elderly patients, and as a practical screening tool to identify older and younger patients at risk for suboptimal clinical outcomes. Chronological age alone is a poor predictor of dose reductions/delays, toxicities, or ability to complete therapy. Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Amgen, Inc.
Suppurative Ear, Nose, and Throat Disease
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Nafcillin-induced agranulocytosis
Authors: S. M. Markowitz
Journal: JAMA (1975)

ADVERSE REACTIONS to the penicillins are relatively common<sup>1</sup>and are clinically expressed in various ways,<sup>2</sup>probably through different mechanisms.<sup>3</sup>An infrequent complication of penicillin therapy is agranulocytosis, first reported with the semisynthetic penicillin, methicillin.<sup>4</sup>Nafcillin (6-[2-ethoxy-l-naphthamido] penicillin) is structurally similar to methicillin. However, to our knowledge, reports of agranulocytosis resulting from nafcillin have not been published. <h3>Report of a Case</h3> A 44-year-old housewife was admitted to the Medical College of Virginia Hospitals on Sept 23, 1974, with a partially treated<i>Staphylococcus aureus</i>endocarditis with tricuspid-valve involvement and septic pulmonary emboli. On physical examination she appeared weak, but well nourished and in no acute distress. Her temperature was 39.2 C (102.6 F); blood pressure, 105/70 mm Hg; and pulse rate, 110 beats per minute. Prominent jugular pulsations ("v" waves) were noted. A grade 3/6 harsh systolic murmur was heard at the second left intercostal space. The rest